![]() |
Market Research Report
China Diabetes Market Report: 2019-2024 |
||||||
Published by | IMARC Services Private Limited | Product code | 345918 | ||||
Published | Content info | 92 Pages Delivery time: 2-3 business days |
|||||
Price |
|
China Diabetes Market Report: 2019-2024 | ||
Published: June 10, 2019 | Content info: 92 Pages |
|
China currently has the highest number of diabetics in the world. The disease has presently reached epidemic proportions in the adult population. Around three decades ago, less than one percent of the Chinese adult population had diabetes. These levels, however, have increased to around 12 percent - making it the diabetes capital of the world.
The rise of diabetes in China can be attributed to a number of factors. Driven by a strong economic growth over the past few decades, the Chinese population has become richer, fatter and less mobile. Apart from urbanisation and sedentary lifestyles, Chinese people are also genetically more vulnerable to diabetes compared to Europeans and many other population groups. Other factors such as poor awareness of health issues, high consumption of white rice, poor healthcare infrastructure, etc. have also driven the prevalence of the disease.
China's diabetes statistics may ring alarm bells for the government and healthcare authorities, for drug and diagnostic manufacturers, however, it represents a goldmine. Fuelled by a continuous increase in healthcare expenditures, the market for diabetes drugs and diagnostics is expanding robustly in the country. This is creating lucrative opportunities for global healthcare companies at a time when growth rates in the more developed markets have declined.
According to the latest report by IMARC Group, titled "China Diabetes Market Report: 2019-2024", the China diabetes market reached a value of US$ 3.37 Billion in 2018, exhibiting a CAGR of 12.48% during 2011-2018. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in China. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Chinese diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the China diabetes market in any form.